← All Sponsors
SPONSOR

Samsung Medical Center

Total Trials
16
Recruiting
16
Phases
Phase 3, Phase 2, Phase 4

Samsung Medical Center is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter, Lymphoma.

The trial portfolio spans Phase 3, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Samsung Medical Center

How many clinical trials has Samsung Medical Center sponsored?
ClinicalMetric currently tracks 16 clinical trials sponsored by Samsung Medical Center, of which 16 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Samsung Medical Center research focus on?
Samsung Medical Center clinical trials span Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter, Lymphoma, Ischemic Heart Disease, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Samsung Medical Center clinical trial?
To participate in a Samsung Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Samsung Medical Center trials with current recruitment status updated daily.

Clinical Trials by Samsung Medical Center

NCT07447297
Recruiting

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

Atrial Fibrillation (AF)
NCT07032103
Recruiting

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

Lymphoma
NCT07009418
Recruiting

Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)

Ischemic Heart Disease
NCT02798705
Recruiting

Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis

Cardiac Amyloidosis
NCT07128446
Recruiting

COPM-Based Goal Setting Strategies in the PICU

Critical Illness
NCT05893966
Recruiting

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

Breast Cancer
NCT07500701 Phase 3
Recruiting

Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer

Prostate Cancer
NCT07381231 Phase 2
Recruiting

Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors

Cancer
NCT07806994
Recruiting

Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy

Cerebral Palsy (CP)
NCT05812963
Recruiting

IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI

ST Elevation Myocardial Infarction
NCT06270238
Recruiting

Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients

Stroke
NCT05444452
Recruiting

GENOSS Coronary Stent Clinical Trial

Ischemic Heart Disease
NCT07121335
Recruiting

SMC Radiation Oncology SABR Cohort for Oligometastasis

Stereotactic Body Radiation Therapy (SBRT)
NCT07559123
Recruiting

Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

NSCLC
NCT05896865
Recruiting

Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer

Breast Cancer Stage III
NCT07753200 Phase 4
Recruiting

Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease

Atrial Fibrillation (AF)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology